565 related articles for article (PubMed ID: 11337540)
1. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.
Ishii K; Willoch F; Minoshima S; Drzezga A; Ficaro EP; Cross DJ; Kuhl DE; Schwaiger M
J Nucl Med; 2001 Apr; 42(4):548-57. PubMed ID: 11337540
[TBL] [Abstract][Full Text] [Related]
2. Construction and comparative evaluation of different activity detection methods in brain FDG-PET.
Buchholz HG; Wenzel F; Gartenschläger M; Thiele F; Young S; Reuss S; Schreckenberger M
Biomed Eng Online; 2015 Aug; 14():79. PubMed ID: 26281849
[TBL] [Abstract][Full Text] [Related]
3. Comparison of SPM and NEUROSTAT in voxelwise statistical analysis of brain SPECT and MRI at the early stage of Alzheimer's disease.
Nishimiya M; Matsuda H; Imabayashi E; Kuji I; Sato N
Ann Nucl Med; 2008 Dec; 22(10):921-7. PubMed ID: 19142712
[TBL] [Abstract][Full Text] [Related]
4. Validation of anatomical standardization of FDG PET images of normal brain: comparison of SPM and NEUROSTAT.
Hosaka K; Ishii K; Sakamoto S; Sadato N; Fukuda H; Kato T; Sugimura K; Senda M; ;
Eur J Nucl Med Mol Imaging; 2005 Jan; 32(1):92-7. PubMed ID: 15322767
[TBL] [Abstract][Full Text] [Related]
5. Comparison of gray matter and metabolic reduction in mild Alzheimer's disease using FDG-PET and voxel-based morphometric MR studies.
Ishii K; Sasaki H; Kono AK; Miyamoto N; Fukuda T; Mori E
Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):959-63. PubMed ID: 15800784
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional stereotactic surface projection analysis of macaque brain PET: development and initial applications.
Cross DJ; Minoshima S; Nishimura S; Noda A; Tsukada H; Kuhl DE
J Nucl Med; 2000 Nov; 41(11):1879-87. PubMed ID: 11079499
[TBL] [Abstract][Full Text] [Related]
7. Influence of mild hyperglycemia on cerebral FDG distribution patterns calculated by statistical parametric mapping.
Kawasaki K; Ishii K; Saito Y; Oda K; Kimura Y; Ishiwata K
Ann Nucl Med; 2008 Apr; 22(3):191-200. PubMed ID: 18498034
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous PET-MRI Studies of the Concordance of Atrophy and Hypometabolism in Syndromic Variants of Alzheimer's Disease and Frontotemporal Dementia: An Extended Case Series.
Moodley KK; Perani D; Minati L; Della Rosa PA; Pennycook F; Dickson JC; Barnes A; Contarino VE; Michopoulou S; D'Incerti L; Good C; Fallanca F; Vanoli EG; Ell PJ; Chan D
J Alzheimers Dis; 2015; 46(3):639-53. PubMed ID: 26402512
[TBL] [Abstract][Full Text] [Related]
9. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
Vander Borght T; Minoshima S; Giordani B; Foster NL; Frey KA; Berent S; Albin RL; Koeppe RA; Kuhl DE
J Nucl Med; 1997 May; 38(5):797-802. PubMed ID: 9170449
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients.
Jeong Y; Cho SS; Park JM; Kang SJ; Lee JS; Kang E; Na DL; Kim SE
J Nucl Med; 2005 Feb; 46(2):233-9. PubMed ID: 15695781
[TBL] [Abstract][Full Text] [Related]
11. Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease.
Chételat G; Desgranges B; Landeau B; Mézenge F; Poline JB; de la Sayette V; Viader F; Eustache F; Baron JC
Brain; 2008 Jan; 131(Pt 1):60-71. PubMed ID: 18063588
[TBL] [Abstract][Full Text] [Related]
12. Rapid scanning protocol for brain (18)F-FDG PET: a validation study.
Chen WP; Matsunari I; Noda A; Yanase D; Yajima K; Takeda N; Yamada M; Minoshima S; Nishimura S
J Nucl Med; 2005 Oct; 46(10):1633-41. PubMed ID: 16204713
[TBL] [Abstract][Full Text] [Related]
13. Age- and sex-associated changes in cerebral glucose metabolism in normal healthy subjects: statistical parametric mapping analysis of F-18 fluorodeoxyglucose brain positron emission tomography.
Kim IJ; Kim SJ; Kim YK
Acta Radiol; 2009 Dec; 50(10):1169-74. PubMed ID: 19922315
[TBL] [Abstract][Full Text] [Related]
14. Parametric mapping of cerebral blood flow deficits in Alzheimer's disease: a SPECT study using HMPAO and image standardization technique.
Imran MB; Kawashima R; Awata S; Sato K; Kinomura S; Ono S; Yoshioka S; Sato M; Fukuda H
J Nucl Med; 1999 Feb; 40(2):244-9. PubMed ID: 10025830
[TBL] [Abstract][Full Text] [Related]
15. Adjusted scaling of FDG positron emission tomography images for statistical evaluation in patients with suspected Alzheimer's disease.
Buchert R; Wilke F; Chakrabarti B; Martin B; Brenner W; Mester J; Clausen M
J Neuroimaging; 2005 Oct; 15(4):348-55. PubMed ID: 16254400
[TBL] [Abstract][Full Text] [Related]
16. In Alzheimer's disease, hypometabolism in low-amyloid brain regions may be a functional consequence of pathologies in connected brain regions.
Klupp E; Förster S; Grimmer T; Tahmasian M; Yakushev I; Sorg C; Yousefi BH; Drzezga A
Brain Connect; 2014 Jun; 4(5):371-83. PubMed ID: 24870443
[TBL] [Abstract][Full Text] [Related]
17. Direct comparison of spatially normalized PET and SPECT scans in Alzheimer's disease.
Herholz K; Schopphoff H; Schmidt M; Mielke R; Eschner W; Scheidhauer K; Schicha H; Heiss WD; Ebmeier K
J Nucl Med; 2002 Jan; 43(1):21-6. PubMed ID: 11801698
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic PET atlas of the human brain: aid for visual interpretation of functional brain images.
Minoshima S; Koeppe RA; Frey KA; Ishihara M; Kuhl DE
J Nucl Med; 1994 Jun; 35(6):949-54. PubMed ID: 8195881
[TBL] [Abstract][Full Text] [Related]
19. Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.
Küntzelmann A; Guenther T; Haberkorn U; Essig M; Giesel F; Henze R; Schroeter ML; Schröder J; Schönknecht P
Neurosci Lett; 2013 Feb; 534():12-7. PubMed ID: 23182881
[TBL] [Abstract][Full Text] [Related]
20. Brain FDG PET study of normal aging in Japanese: effect of atrophy correction.
Yanase D; Matsunari I; Yajima K; Chen W; Fujikawa A; Nishimura S; Matsuda H; Yamada M
Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):794-805. PubMed ID: 15759148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
